A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
Results - Part B: Analysis of data by pathogen, continued
Ortho/paramyxoviruses
Influenza virus
Influenza is a highly contagious acute respiratory disease which has caused epidemics and pandemics throughout the world for centuries. While most influenza infections are self-limiting, lower respiratory tract and cardiac complications, particularly in the elderly can lead to increased hospitalisations and deaths, particularly during the epidemic months.36Up until 2001, LabVISE has been the only source of laboratory-confirmed influenza data for national influenza surveillance. Viral isolates are forwarded to the World Health Organization Centre for Reference and Research on Influenza for subtype and antigenic analysis. These data have been used to monitor circulating influenza viral strains and to determine the composition of the annual influenza vaccine for Australia.
Influenza reports to LabVISE for 1991 to 2000 are shown in Table 31.
Table 31. Laboratory reports to LabVISE of influenza, 1991 to 2000, by strain type and annual influenza A:B ratio
Virus |
1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Influenza A | 60 |
1,322 |
544 |
1,196 |
797 |
1,641 |
1,447 |
2,746 |
1,932 |
1,506 |
13,191 |
Influenza B | 408 |
126 |
648 |
87 |
355 |
79 |
903 |
149 |
279 |
580 |
3,614 |
Ratio influenza A:B | 0.1 |
10.5 |
0.8 |
13.7 |
2.2 |
20.8 |
1.6 |
18.4 |
6.9 |
2.6 |
The monthly reports to LabVISE of influenza A and B, between 1991 and 2000 are shown in Figure 16. Typically, influenza A is predominant with outbreaks of influenza B every alternate year. Laboratory reports of influenza are largely from young children aged under 5 years.
Figure 16. Laboratory reports to LabVISE of influenza A and influenza B infections, 1991 to 2000, by month of specimen collection
Parainfluenza virus
Human parainfluenza viruses (HPIV) are an important cause of acute respiratory infection in infants and children and are especially associated with laryngotracheobronchitis (croup). In the USA, the parainfluenza viruses are responsible for one-third of the estimated 5 million cases of lower respiratory infections occurring annually in children under 5 years of age.37 Infections also occur in older age groups. Four serotypes are recognised. Biennial epidemics of HPIV-1 and HPIV-2 occur in autumn, while HPIV-3 causes annual epidemics, particularly among young infants aged less than 6 months. LabVISE reports of parainfluenza virus are shown in Table 32.Top of pageTable 32. Laboratory reports to LabVISE of parainfluenza virus, 1991 to 2000, by serotype
Virus |
1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Parainfluenza virus type 1 | 47 |
281 |
44 |
548 |
32 |
315 |
61 |
276 |
44 |
230 |
1,878 |
Parainfluenza virus type 2 | 143 |
60 |
127 |
61 |
178 |
73 |
112 |
30 |
114 |
36 |
934 |
Parainfluenza virus type 3 | 556 |
554 |
513 |
526 |
833 |
730 |
962 |
409 |
803 |
516 |
6,402 |
Parainfluenza virus type 4 | - |
- |
- |
- |
2 |
7 |
- |
3 |
2 |
- |
14 |
Parainfluenza virus typing pending | 59 |
80 |
46 |
68 |
36 |
32 |
239 |
5 |
1 |
1 |
567 |
Total | 805 |
975 |
730 |
1,203 |
1,081 |
1,157 |
1,374 |
723 |
964 |
783 |
9,795 |
Laboratory reports of parainfluenza by serotype and month between 1991 and 2000 are shown in Figure 17. There are annual epidemics of parainfluenza type 3, while parainfluenza types 1 and 2 occur in biennial epidemics in alternate years in Australia. Laboratory reports to LabVISE for parainfluenza were predominantly for children aged 0-4 years. In 2000, 68 per cent of HPIV-1, 53 per cent of HPIV-2 and 68 per cent of HPIV-3 occurred in children aged 0-4 years.
Figure 17. Laboratory reports to LabVISE of human parainfluenza serotypes 1, 2 and 3, 1991 to 2000, by month of specimen collection
HPIV-1 human parainfluenza serotype 1
HPIV-2 human parainfluenza serotype 2
HPIV-3 human parainfluenza serotype 3
Respiratory syncytial virus
Respiratory syncytial virus (RSV) infects almost all people in all regions of the world within the first years of life and is the major cause of lower respiratory illness in young children. RSV is an important cause of community-acquired pneumonia.38 A recent study from the United Kingdom suggests that RSV infection may be confused with influenza-like illness.39 RSV identifications were the single most common virus reported in LabVISE (14.3% of total between 1991 and 2000). LabVISE reports of RSV are shown in Table 33.Table 33. Laboratory reports to LabVISE of respiratory syncytial virus, 1991 to 2000
Virus |
1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Respiratory syncytial virus | 2,555 |
3,556 |
3,506 |
3,749 |
3,889 |
4,068 |
4,588 |
4,641 |
3,059 |
2,735 |
36,346 |
RSV epidemics occur annually in the winter months (Figure 18) and most patients are aged between 0-4 years. Thus of 2,735 reports in 2000, 2,446 (89.4%) were in children aged less than 5 years.
Figure 18. Laboratory reports to LabVISE of respiratory syncytial virus infection, 1991 to 2000, by month of specimen collection
This article was published in Communicable Diseases Intelligence Volume 26, No 3, September 2002
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
CDI Vol 26, No 3, September 2002
LabVISE, 1991 to 2000
- Contents and Abbreviations
- Abstract and Authors
- Introduction and Methods
- Part A: General results
- Part A: General results cont
- Part B: Analysis of data by pathogen
- Discussion
- Appendices
- References
Communicable Diseases Intelligence